UnitedHealth Group Stock Price Rises 3.2%

Is Now the Time to Buy the Healthcare Giant's Shares?

Published on Feb. 14, 2026

Got story updates? Submit your updates here. ›

UnitedHealth Group's (NYSE:UNH) stock price jumped 3.2% during mid-day trading on Friday, reaching as high as $293.46 per share before closing at $293.33. The healthcare conglomerate saw trading volume of over 10 million shares, down 8% from the average daily volume.

Why it matters

UnitedHealth Group is one of the largest healthcare companies in the United States, providing insurance and services to millions of individuals, employers, and government programs. Its stock performance is closely watched as an indicator of the broader healthcare industry's health and investor sentiment.

The details

Several equity analysts have recently issued reports on UnitedHealth Group, with some lowering their price targets due to concerns about the company's outlook. However, the majority of analysts maintain a 'Buy' rating on the stock, citing UnitedHealth's diversified business model and strong market position.

  • UnitedHealth Group's stock price shot up 3.2% during mid-day trading on Friday, February 13, 2026.

The players

UnitedHealth Group Incorporated

A diversified healthcare company that operates two primary business platforms: UnitedHealthcare and Optum. UnitedHealth Group provides a broad range of health benefits and healthcare services to individuals, employers, governmental entities, and other organizations in the United States and selected international markets.

Truist Financial

A financial services company that recently decreased its target price for UnitedHealth Group from $410 to $370, while maintaining a 'Buy' rating on the stock.

Deutsche Bank Aktiengesellschaft

A global banking and financial services company that downgraded UnitedHealth Group from 'Buy' to 'Hold' and set a target price of $333.

Morgan Stanley

A multinational investment bank and financial services company that lowered its price target for UnitedHealth Group from $411 to $409, while maintaining an 'Overweight' rating.

Royal Bank of Canada

A Canadian multinational financial services company that decreased its target price for UnitedHealth Group from $408 to $361, while maintaining an 'Outperform' rating.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

UnitedHealth Group's stock price surge highlights the company's resilience and strong market position, even as some analysts express concerns about the healthcare industry's outlook. Investors will be closely watching the company's future performance and any potential changes in analyst sentiment.